162 related articles for article (PubMed ID: 8482460)
1. Circulating levels of endothelin in cirrhosis.
Asbert M; Ginès A; Ginès P; Jiménez W; Clària J; Saló J; Arroyo V; Rivera F; Rodés J
Gastroenterology; 1993 May; 104(5):1485-91. PubMed ID: 8482460
[TBL] [Abstract][Full Text] [Related]
2. Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems.
Bernardi M; Gulberg V; Colantoni A; Trevisani F; Gasbarrini A; Gerbes AL
J Hepatol; 1996 Feb; 24(2):161-8. PubMed ID: 8907569
[TBL] [Abstract][Full Text] [Related]
3. Atrial natriuretic factor in cirrhotic patients with tense ascites. Effect of large-volume paracentesis.
Salerno F; Badalamenti S; Moser P; Lorenzano E; Incerti P; Dioguardi N
Gastroenterology; 1990 Apr; 98(4):1063-70. PubMed ID: 2138104
[TBL] [Abstract][Full Text] [Related]
4. Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function.
Trevisani F; Colantoni A; Gerbes AL; Gülberg V; Sica G; Caraceni P; De Notariis S; Morselli-Labate AM; Ligabue A; Gasbarrini G; Bernardi M
J Hepatol; 1997 Apr; 26(4):808-15. PubMed ID: 9126793
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of elevated plasma endothelin concentration in patients with cirrhosis.
Uchihara M; Izumi N; Sato C; Marumo F
Hepatology; 1992 Jul; 16(1):95-9. PubMed ID: 1535610
[TBL] [Abstract][Full Text] [Related]
6. Plasma endothelin levels in cirrhotic subjects.
Veglio F; Pinna G; Melchio R; Rabbia F; Panarelli M; Gagliardi B; Chiandussi L
J Hepatol; 1992 May; 15(1-2):85-7. PubMed ID: 1387139
[TBL] [Abstract][Full Text] [Related]
7. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume.
Saló J; Francitorra A; Follo A; Navasa M; Ginès A; Jiménez W; Ginès P; Arroyo V; Rivera F; Rodés J
J Hepatol; 1995 Apr; 22(4):389-98. PubMed ID: 7665857
[TBL] [Abstract][Full Text] [Related]
9. Plasma endothelin levels in patients with cirrhosis and their relationships to the severity of cirrhosis and renal function.
Tsai YT; Lin HC; Yang MC; Lee FY; Hou MC; Chen LS; Lee SD
J Hepatol; 1995 Dec; 23(6):681-8. PubMed ID: 8750167
[TBL] [Abstract][Full Text] [Related]
10. Relation of endothelins to volume regulating neurohumoral systems in patients with cirrhosis of the liver.
Gülberg V; Gerbes AL
Eur J Clin Invest; 1995 Dec; 25(12):893-8. PubMed ID: 8719927
[TBL] [Abstract][Full Text] [Related]
11. Urinary endothelin-like immunoreactivity in patients with cirrhosis.
Saló J; Fernández-Esparrach G; Ginès P; Ginès A; Guevara M; Sort P; Jiménez W; Arroyo V; Rivera F; Rodés J
J Hepatol; 1997 Nov; 27(5):810-6. PubMed ID: 9382967
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of brain natriuretic peptide in patients with cirrhosis.
La Villa G; Romanelli RG; Casini Raggi V; Tosti-Guerra C; De Feo ML; Marra F; Laffi G; Gentilini P
Hepatology; 1992 Jul; 16(1):156-61. PubMed ID: 1618467
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of plasma endothelin-1 in patients with chronic liver disease.
Matsumoto H; Uemasu J; Kitano M; Kawasaki H
Dig Dis Sci; 1994 Dec; 39(12):2665-70. PubMed ID: 7995194
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
15. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis.
Simón MA; Díez J; Prieto J
Gastroenterology; 1991 Nov; 101(5):1354-60. PubMed ID: 1936807
[TBL] [Abstract][Full Text] [Related]
16. Systemic nitric oxide production and renal function in nonazotemic human cirrhosis: a reappraisal.
Sansoè G; Silvano S; Mengozzi G; Smedile A; Todros L; Baronio M; Bonardi L; Rizzetto M
Am J Gastroenterol; 2002 Sep; 97(9):2383-90. PubMed ID: 12358261
[TBL] [Abstract][Full Text] [Related]
17. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
[TBL] [Abstract][Full Text] [Related]
18. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Burghardt W; Müller R; Diehl KL; Wernze H
Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
[TBL] [Abstract][Full Text] [Related]
19. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.
Pérez-Ayuso RM; Arroyo V; Camps J; Rimola A; Costa J; Gaya J; Rivera F; Rodés J
Hepatology; 1984; 4(2):247-52. PubMed ID: 6368354
[TBL] [Abstract][Full Text] [Related]
20. Elevated endothelin-1 in heart failure and loss of normal response to postural change.
Stewart DJ; Cernacek P; Costello KB; Rouleau JL
Circulation; 1992 Feb; 85(2):510-7. PubMed ID: 1346510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
